Clinical trials
Diabetes clinical trials
Below are recruiting diabetes clinical trials, each written for real people, not researchers. We’re tracking 2,211 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05570734Recruiting
Study of diabetes support for Hispanic/Latino adults online
This study looks at an online (e-health) way to help adults with type 2 diabetes better follow their diabetes care plan. It targets Hispanic/Latino patients and may help improve how consistently people manage their diabetes.
Chula Vista, CaliforniaAges 18 years+ - NCT05572502Recruiting
Online program for type 2 diabetes reversal goals
This trial studies an online program designed to help people with type 2 diabetes improve their health and diabetes control. You may be able to join if you already have type 2 diabetes and can follow the study plan and your current medication routine.
Washington D.C., District of ColumbiaAges 18 years+ - NCT05584293Recruiting
Diabetes registry for adults with diabetes in hospital care
This study sets up a diabetes registry, which means collecting information about people’s diabetes care in a hospital clinic. It may help improve understanding of how diabetes is managed in real life, which can support better future care.
Almelo, OverijsselAges 18 years+ - NCT05585983RecruitingPhase 4
Flu shot in newly diagnosed type 1 diabetes patients
This trial checks whether giving a flu vaccine to people who were just diagnosed with type 1 diabetes affects their health and immune response. It may help doctors understand if flu vaccination is safe and useful soon after diagnosis.
AalborgAges 7–17 - NCT05593081Recruiting
Study of sudden type 1 diabetes after rapid symptom onset
This trial studies people who develop severe, fast-onset “type 1 diabetes” with body-wide stress (ketosis/ketoacidosis) soon after symptoms start. It aims to better understand this condition and how to care for it early.
Quanzhou, FujianAges Any age - NCT05593549RecruitingEarly Phase 1
Studying blood vessel damage in type 2 diabetes
This early study looks at how “autophagy” (your body’s cell recycling process) relates to small blood-vessel problems in people with type 2 diabetes. It may help researchers understand mechanisms and possible future treatments, mainly for people who meet specific health and medication criteria.
Milwaukee, WisconsinAges 18–80 - NCT05594706Recruiting
Anhydroglucitol test in children with type 1 diabetes
This trial studies how anhydroglucitol behaves in children with type 1 diabetes who use insulin pump therapy and glucose monitoring. Your team will compare measurements over about a year to see if this marker could be useful for tracking diabetes control.
Geneva, Canton of GenevaAges 2–18 - NCT05597709Recruiting
Study diabetes patients to measure MAFLD in Jiangsu
This study checks how common a condition called MAFLD is among people with type 2 diabetes in Jiangsu, China. It may help doctors understand how often this liver-related problem occurs and guide future care for people with type 2 diabetes.
Nanjing, JiangsuAges 18 years+ - NCT05598203Recruiting
Nutrition education groups for adults with type 2 diabetes
This trial studies whether attending group sessions about nutrition can help adults with type 2 diabetes manage their health better. It may be most helpful if your diabetes is not yet well controlled and you can safely participate in group education.
Porto Alegre, Rio Grande do SulAges Any age - NCT05605704RecruitingPhase 2/Phase 3
Olive leaf extract for controlling diabetes
This trial studies whether olive leaf extract can help control diabetes. If you’re an adult with diabetes, you may be eligible to join and see how this supplement affects your blood sugar.
Monastir, Monastir TunisiaAges 18–100 - NCT05613985Recruiting
Ultrasound light added to usual care for infected diabetic foot ulcers
This trial tests whether adding the VULNOFAST Plus/VULNOLIGHT system to usual care can heal infected diabetic foot ulcers more safely and effectively. It compares the added treatment plus usual care versus usual care alone.
ArezzoAges 18 years+ - NCT05616026Recruiting
Text message support to improve diabetes control
This trial tests whether regular text messages can help people who are homeless manage type 2 diabetes better. It focuses on improving blood sugar control, often tracked by a lab result called HbA1c.
Washington D.C., District of ColumbiaAges 21 years+ - NCT05623111RecruitingPhase 2
Nerve-area Botox shots for diabetic foot nerve pain
This Phase 2 trial tests whether injecting incobotulinumtoxin-A near painful nerves can reduce nerve-type pain in the feet for people with diabetes. If you have lasting, fairly symmetrical pain in both feet, the injections may help calm the nerve pain signals.
Glostrup MunicipalityAges 18 years+ - NCT05630508Recruiting
Diabetes lifestyle app for Arabic-speaking adults
This trial tests a lifestyle coaching app on a phone to help adults with type 2 diabetes improve blood sugar. It may help if your diabetes is currently not well controlled.
Riyadh, Riyadh RegionAges 18 years+ - NCT05633628Recruiting
Wear a continuous glucose monitor with type 2 diabetes
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
StockholmAges 18–80 - NCT05633810RecruitingPhase 3
Testing colchicine plus coated aspirin to prevent heart events
This Phase 3 study tests whether colchicine and a special type of aspirin can lower the risk of future heart attacks, strokes, or other major heart problems in people with type 2 diabetes who have not had a prior heart event. It aims to reduce cardiovascular risk using medicines that may calm inflammation and protect blood vessels.
Bentley, Western AustraliaAges 55–80 - NCT05641753RecruitingPhase 4
LDL-lowering study for adults with type 1 diabetes
This study looks at cholesterol lowering in adults with type 1 diabetes and whether it reduces “residual risk,” meaning risk that may remain even with current care. You may be asked to take cholesterol-focused treatment and complete blood tests to track LDL (“bad cholesterol”).
New York, New YorkAges 18–89 - NCT05651919Recruiting
Blood test study to understand diabetic heart weakness
This study measures immune cells from your blood to find markers (biomarkers) that may explain or predict diabetic cardiomyopathy, a type of heart condition linked to diabetes. You may benefit mainly by being closely monitored and contributing to research that could improve future diagnosis or risk tracking.
BronAges 40–85 - NCT05653518Recruiting
Artificial pancreas therapy to steady sugars and protect the heart
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
Charlottesville, VirginiaAges 18–40 - NCT05662189Recruiting
PET scan study of beta cell function in diabetes
This study uses a special PET scan to measure how well insulin-producing cells (“beta cells”) in the pancreas are working in people with diabetes. It’s meant to help researchers understand diabetes biology and test whether the scan can reflect beta cell function.
Parma, PrAges 18–75 - NCT05687968Recruiting
Using phone food logs to improve diabetes care
This study tests an approach to diabetes care that relies on you recording what you eat using a smartphone. It may help the research team learn how food patterns relate to blood sugar and how to improve care.
TaipeiAges 20 years+ - NCT05697991Recruiting
Study of fatty liver in adults with type 2 diabetes
This study looks at people with type 2 diabetes who also have fatty liver. The goal is to learn more about this condition in a Saudi group and test approaches that could improve care.
Riyadh, Select A State Or ProvinceAges 18–60 - NCT05700877RecruitingPhase 4
Screening and treatment for silent heart artery disease in type 2 diabetes
This trial tests a screening and intervention approach for “silent” coronary artery disease (heart artery narrowing without major symptoms) in people with type 2 diabetes. It may help prevent future heart problems by finding higher-risk cases early and starting the right treatment plan.
OdenseAges 55–75 - NCT05701254Recruiting
Study how type 1 diabetes affects fracture risk bones
This study compares bone structure in women with type 1 diabetes versus women without diabetes, to understand why fractures can happen more easily. You may need blood tests, scans, and a small bone biopsy (a surgical sample from your hip/thigh area).
Omaha, NebraskaAges 50 years+
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes?
- Yes. Clin2 currently lists 2,211 recruiting diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.